Need Help?

Raw microarray gene expression data from NPC samples_Cohort 1

We retrospectively collected 150 non-metastatic, pretreatment, formalin-fixed, paraffin-embedded (FFPE) nasopharyngeal carcinoma (NPC) samples as validation cohort 1. Also, we prospectively collected 32 FFPE samples from NPC patients enrolled in a trial evaluating anti-PD-1 antibody as validation cohort 2. Total RNA was extracted and hybridised to an Affymetrix HTA 2.0 microarray. In this study, we investigated the immune status of the tumour microenvironment (TME) based on gene expression profiles to classify NPC into biologically distinct immune subtypes, and clarify their associations with prognosis and immunotherapy response.

Request Access

The NPC GEP DAC determines access permissions.

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom NPC GEP DAC grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: Jun Ma and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. XXXXX: Your Institution details here 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify NPC GEP DAC within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify NPC GEP DAC prior to any significant changes to the protocol for the Project. 14. The User Institution will notify NPC GEP DAC as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. NPC GEP DAC may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than Jun Ma. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001004542 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00004171723 gz 17.6 MB
EGAF00004171724 gz 17.3 MB
EGAF00004171725 gz 16.8 MB
EGAF00004171726 gz 16.3 MB
EGAF00004171727 gz 16.0 MB
EGAF00004171728 gz 17.1 MB
EGAF00004171729 gz 16.8 MB
EGAF00004171730 gz 17.7 MB
EGAF00004171731 gz 17.5 MB
EGAF00004171732 gz 16.3 MB
EGAF00004171733 gz 16.2 MB
EGAF00004171734 gz 16.9 MB
EGAF00004171735 gz 14.0 MB
EGAF00004171736 gz 19.7 MB
EGAF00004171737 gz 18.9 MB
EGAF00004171738 gz 18.5 MB
EGAF00004171739 gz 18.6 MB
EGAF00004171740 gz 19.2 MB
EGAF00004171741 gz 18.4 MB
EGAF00004171742 gz 19.6 MB
EGAF00004171743 gz 19.1 MB
EGAF00004171744 gz 18.9 MB
EGAF00004171745 gz 18.1 MB
EGAF00004171746 gz 18.3 MB
EGAF00004171747 gz 18.4 MB
EGAF00004171748 gz 18.0 MB
EGAF00004171749 gz 17.7 MB
EGAF00004171750 gz 19.1 MB
EGAF00004171751 gz 19.1 MB
EGAF00004171752 gz 18.3 MB
EGAF00004171753 gz 19.2 MB
EGAF00004171754 gz 18.7 MB
EGAF00004171755 gz 18.7 MB
EGAF00004171756 gz 16.2 MB
EGAF00004171757 gz 14.5 MB
EGAF00004171758 gz 16.6 MB
EGAF00004171759 gz 15.1 MB
EGAF00004171760 gz 16.1 MB
EGAF00004171761 gz 15.1 MB
EGAF00004171762 gz 15.4 MB
EGAF00004171763 gz 15.8 MB
EGAF00004171764 gz 15.7 MB
EGAF00004171765 gz 16.6 MB
EGAF00004171766 gz 17.1 MB
EGAF00004171767 gz 16.7 MB
EGAF00004171768 gz 16.9 MB
EGAF00004171769 gz 15.5 MB
EGAF00004171770 gz 17.4 MB
EGAF00004171771 gz 15.2 MB
EGAF00004171772 gz 16.4 MB
EGAF00004171773 gz 16.1 MB
EGAF00004171774 gz 16.4 MB
EGAF00004171775 gz 16.8 MB
EGAF00004171776 gz 13.9 MB
EGAF00004171777 gz 14.3 MB
EGAF00004171778 gz 14.4 MB
EGAF00004171779 gz 15.4 MB
EGAF00004171780 gz 14.3 MB
EGAF00004171781 gz 13.7 MB
EGAF00004171782 gz 14.1 MB
EGAF00004171783 gz 14.9 MB
EGAF00004171784 gz 13.1 MB
EGAF00004171785 gz 14.0 MB
EGAF00004171786 gz 12.9 MB
EGAF00004171787 gz 14.0 MB
EGAF00004171788 gz 14.2 MB
EGAF00004171789 gz 14.2 MB
EGAF00004171790 gz 13.6 MB
EGAF00004171791 gz 14.8 MB
EGAF00004171792 gz 13.2 MB
EGAF00004171793 gz 14.3 MB
EGAF00004171794 gz 14.5 MB
EGAF00004171795 gz 14.5 MB
EGAF00004171796 gz 14.0 MB
EGAF00004171797 gz 14.4 MB
EGAF00004171798 gz 13.9 MB
EGAF00004171799 gz 14.8 MB
EGAF00004171800 gz 12.4 MB
EGAF00004171801 gz 14.6 MB
EGAF00004171802 gz 13.0 MB
EGAF00004171803 gz 13.9 MB
EGAF00004171804 gz 14.0 MB
EGAF00004171805 gz 12.9 MB
EGAF00004171806 gz 12.5 MB
EGAF00004171807 gz 12.6 MB
EGAF00004171808 gz 14.1 MB
EGAF00004171809 gz 15.6 MB
EGAF00004171810 gz 15.2 MB
EGAF00004171811 gz 17.3 MB
EGAF00004171812 gz 17.3 MB
EGAF00004171813 gz 16.9 MB
EGAF00004171814 gz 17.1 MB
EGAF00004171815 gz 16.3 MB
EGAF00004171816 gz 17.3 MB
EGAF00004171817 gz 17.5 MB
EGAF00004171818 gz 17.4 MB
EGAF00004171819 gz 16.9 MB
EGAF00004171821 gz 16.8 MB
EGAF00004171822 gz 17.4 MB
EGAF00004171823 gz 15.9 MB
EGAF00004171824 gz 16.7 MB
EGAF00004171825 gz 13.6 MB
EGAF00004171826 gz 14.6 MB
EGAF00004171827 gz 13.6 MB
EGAF00004171828 gz 13.9 MB
EGAF00004171829 gz 14.2 MB
EGAF00004171830 gz 17.6 MB
EGAF00004171831 gz 17.6 MB
EGAF00004171832 gz 18.0 MB
EGAF00004171833 gz 16.5 MB
EGAF00004171834 gz 14.2 MB
EGAF00004171835 gz 16.9 MB
EGAF00004171836 gz 17.7 MB
EGAF00004171837 gz 17.5 MB
EGAF00004171838 gz 15.5 MB
EGAF00004171839 gz 16.8 MB
EGAF00004171840 gz 17.0 MB
EGAF00004171841 gz 17.5 MB
EGAF00004171842 gz 17.5 MB
EGAF00004171843 gz 15.0 MB
EGAF00004171844 gz 16.3 MB
EGAF00004171845 gz 17.2 MB
EGAF00004171846 gz 17.2 MB
EGAF00004171847 gz 17.5 MB
EGAF00004171849 gz 17.6 MB
EGAF00004171850 gz 18.1 MB
EGAF00004171851 gz 15.9 MB
EGAF00004171852 gz 16.5 MB
EGAF00004171853 gz 17.6 MB
EGAF00004171854 gz 16.9 MB
EGAF00004171855 gz 16.2 MB
EGAF00004171856 gz 17.5 MB
EGAF00004171857 gz 17.3 MB
EGAF00004171858 gz 16.8 MB
EGAF00004171859 gz 18.1 MB
EGAF00004171860 gz 18.0 MB
EGAF00004171861 gz 18.4 MB
EGAF00004171862 gz 16.8 MB
EGAF00004171863 gz 17.5 MB
EGAF00004171864 gz 17.7 MB
EGAF00004171865 gz 17.4 MB
EGAF00004171866 gz 17.6 MB
EGAF00004171867 gz 18.2 MB
EGAF00004171868 gz 17.3 MB
EGAF00004171869 gz 16.5 MB
EGAF00004171870 gz 17.6 MB
EGAF00004171871 gz 18.6 MB
EGAF00004171873 gz 17.3 MB
148 Files (2.4 GB)